東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

A cost-utility analysis of pacemaker...

Mitton, Craig Roy.

FindBook

Google Book

Amazon

博客來

A cost-utility analysis of pacemakers for the treatment of neurally mediated syncope.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	A cost-utility analysis of pacemakers for the treatment of neurally mediated syncope./
作者:	Mitton, Craig Roy.
面頁冊數:	96 p.
附註:	Source: Masters Abstracts International, Volume: 37-03, page: 0907.
Contained By:	Masters Abstracts International37-03.
標題:	Health Sciences, Medicine and Surgery. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=MQ34979
ISBN:	0612349799

A cost-utility analysis of pacemakers for the treatment of neurally mediated syncope.
Mitton, Craig Roy.

A cost-utility analysis of pacemakers for the treatment of neurally mediated syncope. - 96 p.

Source: Masters Abstracts International, Volume: 37-03, page: 0907.

Thesis (M.Sc.)--University of Calgary (Canada), 1998.

Dual chamber pacing with rate drop sensing (DDD-RDS) is a novel, effective and expensive treatment for patients with very frequent neurally mediated syncope (NMS). Its cost-utility from the payer's perspective is unknown. We studied HRQL as measured with the EQ-5D, and the cost to the health care system, for the year before and the year after receiving a DDD-RDS. Physician billings were obtained from Alberta Health, and inpatient, outpatient and emergency costs including initial pacemaker implants were obtained from the CRHA. Recurring costs were extrapolated over 10 years to the expected life of the pacemaker. HRQL scores significantly improved with pacemaker therapy (p

ISBN: 0612349799Subjects--Topical Terms:

1017756
Health Sciences, Medicine and Surgery.

A cost-utility analysis of pacemakers for the treatment of neurally mediated syncope.
LDR:01837nmm 2200277 4500 001 1817931
005 20060829133407.5
008 130610s1998 eng d
020 $a 0612349799
035 $a (UnM)AAIMQ34979
035 $a AAIMQ34979
040 $a UnM $c UnM
100 1 $a Mitton, Craig Roy. $3 1907276
245 1 2 $a A cost-utility analysis of pacemakers for the treatment of neurally mediated syncope.
300 $a 96 p.
500 $a Source: Masters Abstracts International, Volume: 37-03, page: 0907.
500 $a Adviser: M. Sarah Rose.
502 $a Thesis (M.Sc.)--University of Calgary (Canada), 1998.
520 $a Dual chamber pacing with rate drop sensing (DDD-RDS) is a novel, effective and expensive treatment for patients with very frequent neurally mediated syncope (NMS). Its cost-utility from the payer's perspective is unknown. We studied HRQL as measured with the EQ-5D, and the cost to the health care system, for the year before and the year after receiving a DDD-RDS. Physician billings were obtained from Alberta Health, and inpatient, outpatient and emergency costs including initial pacemaker implants were obtained from the CRHA. Recurring costs were extrapolated over 10 years to the expected life of the pacemaker. HRQL scores significantly improved with pacemaker therapy (p $< $. 001). A low incremental cost per QALY gained was observed for pacemaker treatment of NMS ( $9 942 per QALY gained). This result was robust to variations of expected pacemaker life and treatment effect, and indicates that pacemaker therapy for this population merits public funding.
590 $a School code: 0026.
650 4 $a Health Sciences, Medicine and Surgery. $3 1017756
650 4 $a Health Sciences, Health Care Management. $3 1017922
690 $a 0564
690 $a 0769
710 2 0 $a University of Calgary (Canada). $3 1017619
773 0 $t Masters Abstracts International $g 37-03.
790 1 0 $a Rose, M. Sarah, $e advisor
790 $a 0026
791 $a M.Sc.
792 $a 1998
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=MQ34979